Copyright © Inderes 2011 - present. All rights reserved.

Faron Pharmaceuticals

2.185

 

EUR

 

-10.63 %

Corporate customer

FARON

First North Finland

Biotechnology & Pharmaceuticals

Health Care

5,091 following
Compare
-10.63%
-13.98%
+7.37%
-13.29%
+40.42%
-37.21%
-33.18%
-29.52%
-37.21%

Faron Pharmaceuticals is a medical technology company. The company conducts research and development of therapeutic solutions used for the treatment of immune diseases and various organ damage. The largest operations are in North America and Europe, with hospitals and research institutes as the dominant customer base. In addition to the main business, various value-added services are offered. The head office is located in Turku.

Read more
Market cap
228.61M EUR
Turnover
1.12M EUR
P/E (adj.) (24e)
-7.69
EV/EBIT (adj.) (24e)
-8.91
P/B (24e)
-22.37
EV/S (24e)
58,191.99
Dividend yield-% (24e)
-
Coverage
Recommendation
Accumulate
Target price
2.80 EUR
Updated
11.12.2024
Disclaimer
Antti Siltanen
Antti Siltanen

Analyst

Latest research

Latest analysis report

Released: 11.12.2024

Latest extensive report

Released: 23.08.2022

Financial calendar
27.2
2025

Annual report '24

21.3
2025

General meeting '25

27.8
2025

Interim report Q2'25

Risk
Business risk
Valuation risk
Low
High
ShowingAll content types
Research by
Antti Siltanen

Faron: Towards final read-out in March

Faron reported more detailed interim results of the BEXMAB study at the annual meeting of the American Society of Hematology (ASH). The company is on track for the important final read-out in March, as tolerability and overall response rate have remained at good levels.

Faron Pharmaceuticals

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.